VITAL KSK HOLDINGS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,221 JPY | +1.58% |
|
+3.91% | +16.95% |
| Sales 2022 | 577B 3.64B 292B | Sales 2023 | 580B 3.66B 293B | Capitalization | 46.3B 292M 23.4B |
|---|---|---|---|---|---|
| Net income 2022 | 4.77B 30.11M 2.41B | Net income 2023 | 4.83B 30.5M 2.44B | EV / Sales 2022 | 0.04 x |
| Net cash position 2022 | 15.12B 95.47M 7.64B | Net cash position 2023 | 8.78B 55.43M 4.44B | EV / Sales 2023 | 0.06 x |
| P/E ratio 2022 |
8.36
x | P/E ratio 2023 |
9.64
x | Employees | 3,719 |
| Yield 2022 |
3.27% | Yield 2023 |
4.36% | Free-Float | 63.35% |
More Fundamentals
* Assessed data
More news
| 1 day | +1.58% | ||
| 1 week | +3.91% | ||
| Current month | -2.79% | ||
| 1 month | -4.46% | ||
| 3 months | +7.01% | ||
| 6 months | +24.21% | ||
| Current year | +16.95% |
1 week
1 187.00
1 226.00
1 month
1 139.001 272.00
Current year
1 019.001 378.00
1 year
878.001 378.00
3 years
635.001 378.00
5 years
635.001 378.00
10 years
635.001 378.00
| Managers | Title | Age | Since |
|---|---|---|---|
Taisuke Murai
CEO | Chief Executive Officer | 70 | 31/03/09 |
Isao Kita
DFI | Director of Finance/CFO | - | - |
Ken Suzuki
CHM | Chairman | 75 | 31/03/09 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Ken Suzuki
CHM | Chairman | 75 | 31/03/09 |
Masaaki Manabe
BRD | Director/Board Member | 81 | 31/03/09 |
Taisuke Murai
CEO | Chief Executive Officer | 70 | 31/03/09 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.07% | 32 M€ | +29.67% | ||
| 0.01% | 18 M€ | +16.15% | - | |
| 0.01% | 20,721 M€ | +13.52% | - | |
| 0.01% | 144,586 M€ | +14.49% | ||
| 0.01% | 66,066 M€ | +14.68% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/04/24 | 1,221 | +1.58% | 76,900 |
| 25/04/24 | 1,202 | -1.64% | 95,100 |
| 24/04/24 | 1,222 | +1.16% | 60,600 |
| 23/04/24 | 1,208 | +0.17% | 63,200 |
| 22/04/24 | 1,206 | +2.64% | 52,500 |
Delayed Quote Japan Exchange, April 26, 2024 at 07:00 am
More quotes
VITAL KSK HOLDINGS, INC. is a Japan-based holding company, principally engaged in the wholesale of drugs. The Pharmaceutical Wholesale segment is engaged in the wholesale of pharmaceuticals, diagnostics, medical equipment, materials to hospitals, medical practitioners, pharmacies and other medical institutions. The others business is engaged in dispensing pharmacy business, retail of pharmaceutical products, wholesale of agricultural chemicals and veterinary drugs, transportation business, nursing care business, consulting services for medical institutions, property insurance agency business, real estate brokerage business, as well as parking business.
Sector
Pharmaceuticals
Calendar
12/05/2024
- Q4 2023 Earnings Release
| 1st Jan change | Capi. | |
|---|---|---|
| +16.95% | 389M | |
| +17.35% | 71.39B | |
| +5.38% | 8.59B | |
| +6.69% | 8.19B | |
| -20.96% | 7.91B | |
| +0.49% | 4.54B | |
| +17.12% | 4.31B | |
| -3.38% | 3.93B | |
| -2.61% | 3.86B | |
| +22.08% | 3.64B |
- Stock Market
- Equities
- 3151 Stock
